Oramed Pharmaceuticals Inc (ORMP) — Capital Reinvestment Ratio
Oramed Pharmaceuticals Inc (ORMP) has a Capital Reinvestment Ratio of 0.00x as of June 2024, meaning it reinvests 0% of its operating cash flow ($2.07 Million) in capital expenditures ($17.06). See Oramed Pharmaceuticals Inc (ORMP) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Oramed Pharmaceuticals Inc Capital Reinvestment Ratio (2016–2016)
This chart tracks Oramed Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. Check Oramed Pharmaceuticals Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Oramed Pharmaceuticals Inc (2016–2016)
Year-by-year Capital Reinvestment Ratio for Oramed Pharmaceuticals Inc from 2016 to 2016. For live market cap and broader valuation context, see ORMP market cap.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.00x | $4.66 Million | $9.00K | — |